GCM
LXRX icon

Ghisallo Capital Management’s Lexicon Pharmaceuticals LXRX Stock Holding History

Ghisallo Capital Management’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-500,000
Closed -$1.15M – 149
2023
Q2 		$1.15M Buy
+500,000
New +$1.33M 0.14% 88

Other funds holding LXRX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Ghisallo Capital Management's LXRX Position: Q3 2023 in Review

Ghisallo Capital Management sold out of Lexicon Pharmaceuticals (LXRX) in Q3 2023, closing a stake of 500,000 shares — an estimated $1.15M sold.

Ghisallo Capital Management first reported a position in LXRX in Q2 2023 and held it in 1 quarter. The position peaked at $1.15M in Q2 2023. 112 funds tracked by Wall St. Rank hold LXRX as of Q3 2023.

  • Ghisallo Capital Management reported no remaining Lexicon Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • Ghisallo Capital Management sold 500,000 Lexicon Pharmaceuticals shares in Q3 2023, an estimated $1.15M.
  • Ghisallo Capital Management first reported a position in Lexicon Pharmaceuticals in Q2 2023 and held it in 1 quarter.
  • Ghisallo Capital Management's Lexicon Pharmaceuticals position peaked at $1.15M in Q2 2023.
  • 112 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q3 2023.

Based on Ghisallo Capital Management's 13F filing for Q3 2023, filed 13 Nov 2023.